Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Isola

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Oral Diseases|November 21, 2017
Functional and molecular outcomes of the human masticatory musclesG Isola, G P Anastasi, G Matarese, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Spatial distribution of collagen type I mRNA in Paracentrotus lividus eggs and embryosR Gambino, D P Romancino, M Cervello, et al.
Cancer Letters|September 4, 1995
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS)G Ferrandina, F O Ranelletti, G Scambia, et al.
Oral Diseases|October 12, 2013
Differential expression of transglutaminase genes in patients with chronic periodontitisM Currò, G Matarese, G Isola, et al.
International Journal of Cancer|November 4, 1996
Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cellsR De Vincenzo, G Scambia, P Benedetti Panici, et al.
Annals of the New York Academy of Sciences|April 30, 1996
Chemosensitizing effect of tamoxifen and ICI 182,780 on parental and adriamycin-resistant MCF-7 human breast cancer cellsR de Vincenzo, G Scambia, P Benedetti Panici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative GroupF Boccardo, A Rubagotti, P Bruzzi, et al.
British Journal of Cancer|January 1, 1997
Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosisC Ferlini, G Scambia, M Distefano, et al.
The Journal of Investigative Dermatology|August 1, 1995
Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cellsM Piantelli, N Maggiano, R Ricci, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Oral Diseases|November 21, 2017
Functional and molecular outcomes of the human masticatory musclesG Isola, G P Anastasi, G Matarese, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Spatial distribution of collagen type I mRNA in Paracentrotus lividus eggs and embryosR Gambino, D P Romancino, M Cervello, et al.
Cancer Letters|September 4, 1995
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS)G Ferrandina, F O Ranelletti, G Scambia, et al.
Oral Diseases|October 12, 2013
Differential expression of transglutaminase genes in patients with chronic periodontitisM Currò, G Matarese, G Isola, et al.
International Journal of Cancer|November 4, 1996
Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cellsR De Vincenzo, G Scambia, P Benedetti Panici, et al.
Annals of the New York Academy of Sciences|April 30, 1996
Chemosensitizing effect of tamoxifen and ICI 182,780 on parental and adriamycin-resistant MCF-7 human breast cancer cellsR de Vincenzo, G Scambia, P Benedetti Panici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative GroupF Boccardo, A Rubagotti, P Bruzzi, et al.
British Journal of Cancer|January 1, 1997
Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosisC Ferlini, G Scambia, M Distefano, et al.
The Journal of Investigative Dermatology|August 1, 1995
Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cellsM Piantelli, N Maggiano, R Ricci, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Pageof 4